Table 3.

Multivariate analyses of selected factors for PFS and OS of EGFR-mut NSCLC patients (N=71)

	PFS		OS
HR (95% CI)	P-value	HR (95% CI)	P-value
TP53 mutation		0.03*		0.017*
Wt	1		1
Mut	1.87(1.06–3.29)		2.73(1.20–6.21)
EGFR mutation		0.032*		0.002*
Del19/L858R	1		1
Other mutation	1.98(1.06–3.70)		3.58(1.61–7.94)
Line of therapy		0.017*		0.825
First line	1		1
Non-first line	2.02(1.14–3.58)		1.09(0.51–2.32)

Note: *P<0.05.

Abbreviations: NSCLC, non-small-cell lung cancer; PFS, progression-free survival; OS, overall survival